Clinical Trial Update: EnTRINSIC - EnPulse Trial on Search AV+ Influence [Phase 4]

View source ↗

Summary

The EnPulse EnTRINSIC trial (Phase 4) sponsored by Medtronic was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arrhythmia
• Sinus Node Dysfunction

Snippet

Sponsor: Medtronic Cardiac Rhythm and Heart Failure | Conditions: Arrhythmia, Sinus | Phase 4 | Status: TERMINATED